Literature DB >> 14413062

Antifibrinolytic activity in primary carcinoma of the liver.

H C KWAAN, R LO, A J MCFADZEAN.   

Abstract

Entities:  

Keywords:  CARCINOMA/blood; FIBRINOLYSIN/antagonists; LIVER NEOPLASMS/blood

Mesh:

Substances:

Year:  1959        PMID: 14413062

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  8 in total

1.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  Increase in antihaemophilic globulin activity following infusion of adrenaline.

Authors:  G I INGRAM
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

3.  Reptilase time in cirrhosis and hepatocellular carcinoma.

Authors:  P J Johnson; Y White; I L Woolf; R Williams
Journal:  Br Med J       Date:  1977-10-01

4.  Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.

Authors:  P Fitch; B Bennett; N A Booth; A Croll; S W Ewen
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.

Authors:  D Ogston; N B Bennett; C M Ogston
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

6.  Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.

Authors:  K Leiper; A Croll; N A Booth; N R Moore; T Sinclair; B Bennett
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

Review 7.  Defibrinogenating enzymes.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 8.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.